[HTML][HTML] Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing

HM Sadeghi, I Adeli, D Calina, AO Docea…�- International journal of�…, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is an endocrine-gynecology disorder affecting many
women of childbearing age. Although a part of the involved mechanism in PCOS occurrence�…

[HTML][HTML] Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment

H Zhao, J Zhang, X Cheng, X Nie, B He�- Journal of Ovarian Research, 2023 - Springer
Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by
chronic ovulation dysfunction and overabundance of androgens; it affects 6–20% of women�…

[HTML][HTML] The roles of androgens in humans: biology, metabolic regulation and health

M Alemany�- International journal of molecular sciences, 2022 - mdpi.com
Androgens are an important and diverse group of steroid hormone molecular species. They
play varied functional roles, such as the control of metabolic energy fate and partition, the�…

Efficacy of bariatric surgery in the treatment of women with obesity and polycystic ovary syndrome

L Hu, L Ma, X Xia, T Ying, M Zhou, S Zou…�- The Journal of�…, 2022 - academic.oup.com
Context The comparative effectiveness of drugs and surgical therapy for women with obesity
and polycystic ovary syndrome (PCOS) has not been systematically compared. Objective�…

[HTML][HTML] Immune regulation in polycystic ovary syndrome

Y Luan, L Zhang, Y Peng, Y Li, R Liu, C Yin�- Clinica chimica acta, 2022 - Elsevier
A polycystic ovarian syndrome (PCOS) is the most common endocrine disorder affecting
females. Furthermore, it is a heterogeneous disease with a variety of etiologies and�…

Inflammation and reproductive function in women with polycystic ovary syndrome

LM Velez, M Seldin, AB Motta�- Biology of reproduction, 2021 - academic.oup.com
Polycystic ovary syndrome (PCOS) is one of the most frequent endocrinopathies, affecting 5–
10% of women of reproductive age, and is characterized by the presence of ovarian cysts�…

[HTML][HTML] What can be done to improve polycystic ovary syndrome (PCOS) healthcare? Insights from semi-structured interviews with women in Canada

M Ismayilova, S Yaya�- BMC Women's Health, 2022 - Springer
Background Polycystic ovary syndrome (PCOS) is a common and perplexing condition
affecting metabolic, reproductive, cardiovascular, and psychological health in women�…

[HTML][HTML] Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2�…

K Liu, X He, J Huang, S Yu, M Cui, M Gao, L Liu…�- Clinical�…, 2023 - Springer
Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder characterized by
chronic low-grade inflammation. Previous studies have demonstrated that the gut�…

[HTML][HTML] A rat model of polycystic ovary syndrome with insulin resistance induced by letrozole combined with high fat diet

MX Wang, Q Yin, X Xu�- Medical science monitor: international�…, 2020 - ncbi.nlm.nih.gov
Background Clinically, most patients of polycystic ovary syndrome (PCOS) also have insulin
resistance (IR). The methods for establishing PCOS-IR animal model include using�…

Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress

Y Huang, X Zhang�- American Journal of Physiology�…, 2021 - journals.physiology.org
Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by elevated
secretion of androgen, commonly associated with insulin resistance (IR), which could�…